CLINICAL_TRIALS
trial_result
· 2012-12-31
Clinical Trial Update: Aliskiren Effect on Aortic Plaque Progression [Phase 2, Phase 3]
Summary
A phase 2/3 trial evaluated aliskiren for slowing aortic plaque progression in atherosclerosis. The study was terminated and results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ohio State University | Conditions: Atherosclerosis | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2012-12-31